Disease progression in patients with thin cutaneous melanomas (tumour thickness ≤ 0.75 mm): Clinical and epidemiological data from the Tumour Center Munich 1977-98

British Journal of Dermatology

Volumn 149, Issue 4, 2003, Pages 788-793

  Schmid Wendtner, M H ^a   Baumert, J ^a   Eberle, J ^a   Plewig, G ^a   Volkenandt, M ^a   Sander, C A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cutaneous melanoma; Disease progression; Follow up; Risk factor; Thin melanoma

Indexed keywords

ACROLENTIGINOUS MELANOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; EPIDEMIOLOGICAL DATA; FEMALE; FOLLOW UP; GERMANY; HEAD AND NECK CANCER; HUMAN; LENTIGO MALIGNA MELANOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; RECURRENT CANCER; RISK FACTOR; SEX RATIO; SKIN EXAMINATION; SUPERFICIAL SPREADING MELANOMA; THIN MELANOMA; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0242635665     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05599.x     Document Type: Article

References (25)

1. Clark WH, From L, Berndino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-27.
2. Breslow A. Thickness, cross sectional areas, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-8.
3. Balch CM, Murad TM, Soong SJ et al. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1979; 5: 201-11.
4. Sondergaard K, Schou G. Survival with primary cutaneous melanoma, evaluated from 2012 cases. Virchows Arch Pathol Anat 1985; 406: 179-95.
5. Karakousis CP, Emrich LJ, Rao U. Tumor thickness and prognosis in clinical stage I malignant melanoma. Cancer 1988; 62: 1207-14.
6. Morton DL, Davtyan DG, Wanek LA et al. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993; 71: 3737-43.
7. Balch CM, Murad TM, Soong SJ et al. A multifactorial analysis of melanoma: prognostic histopathologic factors comparing Clark's and Breslow's staging methods. Ann Surg 1978; 188: 732-42.
8. Breslow A, Macht SD. Evaluation of prognosis in stage I cutaneous melanoma. Plast Reconstr Surg 1978; 61: 342-6.
9. Trau H, Rigel DS, Harris MN et al. Metastases of thin melanomas. Cancer 1983; 51: 553-6.
10. Naruns PL, Nizze JA, Cochran AJ et al. Recurrence potential of thin primary melanomas. Cancer 1986; 57: 545-8.
11. Shaw HM, McCarthy WH, McCarthy SW et al. Thin malignant melanomas and recurrence potential. Arch Surg 1987; 122: 1147-50.
12. Slingluff CL Jr, Seigler HF, Vollmer RT, Reintgen DS et al. Lethal 'thin' malignant melanoma: identifying patients at risk [comment]. Ann Surg 1988; 208: 150-61.
13. Shaw HM, Rivers JK, McCarthy SW et al. Cutaneous melanomas exhibiting unusual biologic behavior. World J Surg 1992; 16: 196-202.
14. Pontikes LA, Temple WJ, Cassar SL et al. Influence of level and depth on recurrence rate in thin melanomas. Am J Surg 1993; 165: 225-8.
15. Garbe C, Büttner P, Bertz J et al. Primary cutaneous melanoma: Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 1995; 75: 2484-99.
16. Hundeiker M, Lippold A, Peters A. Metastasizing melanomas with low Breslow-thickness. Hautarzt 1997; 48: 171-4.
17. Vilmer C, Bailly C, Le Doussal V et al. Thin melanomas with unusual aggressive behaviour. J Am Acad Dermatol 1996; 34: 439-44.
18. Massi D, Franchi A, Borgognoni L et al. Thin cutaneous malignant melanomas (≤ 1.5 mm). Identification of risk factors indicative of progression. Cancer 1999; 85: 1067-76.
19. Garbe C, Stadler R, Orfanos CE. Lokalrezidive und Metastasierung bei dünnen malignen Melanomen (≤ 1mm). Hautarzt 1989; 40: 337-43.
20. Fearfield L, Rowe A, Francis N et al. Prognostic factors in very thin melanomas. Br J Dermatol 2002; 147 (Suppl. 62): 14 (Abstr.).
21. Slingluff CL Jr, Seigler HF. Thin malignant melanoma: Risk factors and clinical management. Ann Plast Surg 1992; 28: 89-94.
22. McCarthy WH, Shaw HM, McCarthy SW et al. Cutaneous melanomas that defy conventional prognostic indicators. Semin Oncol 1996; 23: 709-13.
23. Garrison M, Nathanson L. Prognosis and staging in melanoma. Semin Oncol 1996; 23: 725-33.
24. Moloney DM, Gordon DJ, Briggs JC, Rigby HS. Recurrence of thin melanoma: how effective is follow-up? Br J Plast Surg 1996; 49: 409-13.
25. Schmid-Wendtner MH, Baumert J, Wendtner CM et al. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 2001; 145: 981-5.